Home506197 • BOM
add
Bliss GVS Pharma Ltd
Previous close
₹110.35
Day range
₹108.95 - ₹113.50
Year range
₹71.00 - ₹148.95
Market cap
11.51B INR
Avg Volume
46.70K
P/E ratio
15.47
Dividend yield
0.45%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 2.04B | 10.25% |
Operating expense | 811.59M | 30.49% |
Net income | -91.48M | -373.57% |
Net profit margin | -4.49 | -348.07% |
Earnings per share | — | — |
EBITDA | 336.96M | 491.72% |
Effective tax rate | -24.44% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.16B | 216.23% |
Total assets | 12.14B | 4.93% |
Total liabilities | 2.11B | -11.92% |
Total equity | 10.03B | — |
Shares outstanding | 103.95M | — |
Price to book | 1.19 | — |
Return on assets | — | — |
Return on capital | 6.26% | — |
Cash Flow
Net change in cash
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -91.48M | -373.57% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Founded
1984
Website
Employees
763